Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Semiconductor Tech Drug Discovery Company Underway

Neurons on electrodes

A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway

NIH Funding Nanoparticle Gene Therapy for Opioid Disorder

DNA puzzle

National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder. . . . → Read More: NIH Funding Nanoparticle Gene Therapy for Opioid Disorder

New Industry, Academic Studies Arrive at Space Station

International Space Station

Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions. . . . → Read More: New Industry, Academic Studies Arrive at Space Station

Exosomes Shown to Block Broad Covid-19 Variant Range

Exosome illustration

Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range

Biotech Partners on Gene Editing Tech in $1.35B Deal

Gene therapy graphic

A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal

Trial Set for Covid-19 Nasal Spray Vaccine

Nasal spray

A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands. . . . → Read More: Trial Set for Covid-19 Nasal Spray Vaccine

Joint Venture to Develop Stable RNA Covid-19 Vaccine

Shark

A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine

Gene Therapy Delivery Company Gains $26M in Early Funds

DNA puzzle

A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds

Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Blooming cannibis plant

A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal

Brain activity graphic

A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal